-
03 June 2025 23:11:33
- Source: Sharecast
The following amendment has been made to the ' Conversion of Notes and Allotment of Shares' announcement released on 30 May 2025 at 16:00 under RNS No 8603K.
"(Formerly Linton Capital LLP)" has been changed to "(an assignee of Linton Capital LLP, the original Convertible Note holder)".
All other details remain unchanged.
The full amended text is shown below.
Iconic Labs PLC
("Iconic" or the "Company")
Conversion of Notes and Allotment of Shares
Iconic Labs PLC (LSE:ICON), announces that it has received a valid Conversion Notice from Maximum Media Network (an assignee of Linton Capital LLP, the original Convertible Note holder).
The Conversion Notice dated 29 May 2025 provides for 7 Convertible Notes to be converted into 2,023,121 ordinary shares of £0.0001 in the Company ("Ordinary Shares") at a conversion price of GBP 0.0173 at the aggregate principal amount of £35,000.
Application is therefore being made for an aggregate of 2,023,121 new Ordinary Shares to be admitted to trading on the Main Market of the London Stock Exchange which is expected to be on or around 5 June 2025. These shares rank pari passu with the existing Ordinary Shares of the Company.
Following the issue of these shares, the Company's issued ordinary share capital shall consist of 13,379,916 Ordinary Shares. The figure of 13,379,916 represents the total voting rights in the Company and should be used by shareholders as the denominator for the calculation by which they can determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure Guidance & Transparency Rules.
This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the Company's obligations under Article 17 of MAR.
For any further information or enquiries please contact:
|
Iconic Labs John Farquharson, Interim Chief Executive Officer |
via Yellow Jersey PR |
|
Novum Securities Limited David Coffman / Daniel Harris
|
Tel: +44 (0) 20 7399 9400
|
|
Yellow Jersey PR Charles Goodwin Annabelle Wills Bessie Elliot
|
Tel: +44 (0) 20 3004 9512
iconic@yellowjerseypr.com
|
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.